148 related articles for article (PubMed ID: 8383738)
1. Involvement of delta 2 opioid receptors in the development of morphine dependence in mice.
Miyamoto Y; Portoghese PS; Takemori AE
J Pharmacol Exp Ther; 1993 Mar; 264(3):1141-5. PubMed ID: 8383738
[TBL] [Abstract][Full Text] [Related]
2. Involvement of delta 2 opioid receptors in acute dependence on morphine in mice.
Miyamoto Y; Portoghese PS; Takemori AE
J Pharmacol Exp Ther; 1993 Jun; 265(3):1325-7. PubMed ID: 8389861
[TBL] [Abstract][Full Text] [Related]
3. Lack of involvement of delta-1 opioid receptors in the development of physical dependence on morphine in mice.
Miyamoto Y; Bowen WD; Portoghese PS; Takemori AE
J Pharmacol Exp Ther; 1994 Jul; 270(1):37-9. PubMed ID: 8035333
[TBL] [Abstract][Full Text] [Related]
4. Selective blockage of delta opioid receptors prevents the development of morphine tolerance and dependence in mice.
Abdelhamid EE; Sultana M; Portoghese PS; Takemori AE
J Pharmacol Exp Ther; 1991 Jul; 258(1):299-303. PubMed ID: 1649297
[TBL] [Abstract][Full Text] [Related]
5. Involvement of delta 1 and delta 2 opioid receptor subtypes in the development of physical dependence on morphine in mice.
Suzuki T; Tsuji M; Mori T; Misawa M; Nagase H
Pharmacol Biochem Behav; 1997; 57(1-2):293-9. PubMed ID: 9164585
[TBL] [Abstract][Full Text] [Related]
6. Relative involvement of supraspinal and spinal mu opioid receptors in morphine dependence in mice.
Miyamoto Y; Takemori AE
Life Sci; 1993; 52(12):1039-44. PubMed ID: 8383266
[TBL] [Abstract][Full Text] [Related]
7. Modification of mu-opioid agonist-induced locomotor activity and development of morphine dependence by diabetes.
Kamei J; Ohsawa M; Saitoh A; Iwamoto Y; Suzuki T; Misawa M; Nagase H; Kasuya Y
J Pharmacol Exp Ther; 1995 Aug; 274(2):700-6. PubMed ID: 7636731
[TBL] [Abstract][Full Text] [Related]
8. Antisense oligodeoxynucleotides to opioid mu and delta receptors reduced morphine dependence in mice: role of delta-2 opioid receptors.
Sánchez-Blázquez P; García-Espãna A; Garzón J
J Pharmacol Exp Ther; 1997 Mar; 280(3):1423-31. PubMed ID: 9067332
[TBL] [Abstract][Full Text] [Related]
9. Effects of naloxone and D-Phe-Cys-Tyr-D-Trp-Arg-Thr-Pen-Thr-NH2 and the protein kinase inhibitors H7 and H8 on acute morphine dependence and antinociceptive tolerance in mice.
Bilsky EJ; Bernstein RN; Wang Z; Sadée W; Porreca F
J Pharmacol Exp Ther; 1996 Apr; 277(1):484-90. PubMed ID: 8613958
[TBL] [Abstract][Full Text] [Related]
10. In vivo pharmacological characterization of SoRI 9409, a nonpeptidic opioid mu-agonist/delta-antagonist that produces limited antinociceptive tolerance and attenuates morphine physical dependence.
Wells JL; Bartlett JL; Ananthan S; Bilsky EJ
J Pharmacol Exp Ther; 2001 May; 297(2):597-605. PubMed ID: 11303048
[TBL] [Abstract][Full Text] [Related]
11. Antagonism of delta(2)-opioid receptors by naltrindole-5'-isothiocyanate attenuates heroin self-administration but not antinociception in rats.
Martin TJ; Kim SA; Cannon DG; Sizemore GM; Bian D; Porreca F; Smith JE
J Pharmacol Exp Ther; 2000 Sep; 294(3):975-82. PubMed ID: 10945849
[TBL] [Abstract][Full Text] [Related]
12. Precipitation of spinally mediated withdrawal signs by intrathecal administration of naloxone and the mu-receptor antagonist CTP in morphine-dependent mice.
Shook J; Kazmierski W; Hruby V; Burks T
NIDA Res Monogr; 1988; 81():143-8. PubMed ID: 2900467
[TBL] [Abstract][Full Text] [Related]
13. Interactions among mu- and delta-opioid receptors, especially putative delta1- and delta2-opioid receptors, promote dopamine release in the nucleus accumbens.
Hirose N; Murakawa K; Takada K; Oi Y; Suzuki T; Nagase H; Cools AR; Koshikawa N
Neuroscience; 2005; 135(1):213-25. PubMed ID: 16111831
[TBL] [Abstract][Full Text] [Related]
14. A nonpeptidic delta opioid receptor agonist, BW373U86, attenuates the development and expression of morphine abstinence precipitated by naloxone in rat.
Lee PH; McNutt RW; Chang KJ
J Pharmacol Exp Ther; 1993 Nov; 267(2):883-7. PubMed ID: 8246163
[TBL] [Abstract][Full Text] [Related]
15. Modulation of oral morphine antinociceptive tolerance and naloxone-precipitated withdrawal signs by oral Delta 9-tetrahydrocannabinol.
Cichewicz DL; Welch SP
J Pharmacol Exp Ther; 2003 Jun; 305(3):812-7. PubMed ID: 12606610
[TBL] [Abstract][Full Text] [Related]
16. Enhancement of morphine antinociception by a CCKB antagonist in mice is mediated via opioid delta receptors.
Vanderah TW; Bernstein RN; Yamamura HI; Hruby VJ; Porreca F
J Pharmacol Exp Ther; 1996 Jul; 278(1):212-9. PubMed ID: 8764354
[TBL] [Abstract][Full Text] [Related]
17. Chronic agonist treatment converts antagonists into inverse agonists at delta-opioid receptors.
Liu JG; Prather PL
J Pharmacol Exp Ther; 2002 Sep; 302(3):1070-9. PubMed ID: 12183665
[TBL] [Abstract][Full Text] [Related]
18. Role of delta-opioid receptors in mediating the aversive stimulus effects of morphine withdrawal in the rat.
Funada M; Schutz CG; Shippenberg TS
Eur J Pharmacol; 1996 Apr; 300(1-2):17-24. PubMed ID: 8741160
[TBL] [Abstract][Full Text] [Related]
19. Maintenance of morphine dependence by naloxone in acutely dependent mice.
Sofuoglu M; Sato J; Takemori AE
J Pharmacol Exp Ther; 1990 Sep; 254(3):841-6. PubMed ID: 2395116
[TBL] [Abstract][Full Text] [Related]
20. Functional effects of systemically administered agonists and antagonists of mu, delta, and kappa opioid receptor subtypes on body temperature in mice.
Baker AK; Meert TF
J Pharmacol Exp Ther; 2002 Sep; 302(3):1253-64. PubMed ID: 12183687
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
